District court ruled in favor of Watson in Mucinex patent suit


Watson in press release announced that he United States District Court for the Southern District of Florida has ruled that Watson’s generic versions of Mucinex(R), Mucinex(R) D and Mucinex(R) DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252 (the “‘252 Patent”).

A U.S. appeals court in August overturned a ruling that generic-drug maker Perrigo Co. of Allegan, Michigan, didn’t infringe the same patent. That case was sent back to the court for further review.

[CAFC Order in perrigo case]


About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s